Congenital Esotropia Observational Study (CEOS)

NCT00000163 | Completed

• 1 other identifier: NEI-65
• Study Type: observational
• Target: N/A
• Locations: 0 countries
• Sites: N/A

Brief Summary

To observe the early course of congenital esotropia, a form of childhood strabismus. This will determine the probability of spontaneous resolution. Researchers then will try to correlate this finding with various aspects of the esotropia such as the (1) size of the esotropia, (2) variability, and (3) presence of hyperopia. This information will be used to determine the feasibility of conducting a clinical trial to assess the benefit of early surgery for congenital esotropia and, if feasible, to refine eligibility criteria for the trial.

Conditions

Esotropia

Keywords

Congenital Esotropia

Eligibility Criteria

• Age: 4 Weeks - 20 Weeks
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)

Neurologically and developmentally normal infants with congenital esotropia who are between 4 and 20 weeks of age are eligible for CEOS.

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

• National Eye Institute (NEI): lead

MeSH Terms

Conditions

Esotropia

Condition Hierarchy (Ancestors)

Strabismus; Ocular Motility Disorders; Cranial Nerve Diseases; Nervous System Diseases; Eye Diseases

Study Design

• Study Type: observational
• Sponsor Type: NIH

Study Record Dates

• First Submitted: September 23, 1999
• First Posted: September 24, 1999
• Study Start: December 1, 1997
• Study Completion: July 1, 2000
• Last Updated: September 17, 2009

Record last verified: 2009-09